Neovent Cfc- Free Inhaler (Salmeterol)

Salmeterol selectively stimulates β2‑adrenergic receptors on airway smooth‑muscle cells, activating adenylate cyclase and raising cyclic AMP levels. The increased cAMP causes relaxation of the smooth muscle, leading to prolonged bronchodilation that improves airflow and eases breathing in obstructive lung conditions.

The prescribed dose of salmeterol inhalation is determined by the treating physician based on the patient’s disease severity, age, and response to therapy. Typical regimens involve one or two inhalations twice daily, but exact dosing must follow the prescriber’s instructions and local labeling.

Safety data for salmeterol in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Salmeterol is a long‑acting β2‑agonist (LABA) that provides up to 12 hours of bronchodilation, whereas short‑acting β2‑agonists (SABAs) such as albuterol act for 4‑6 hours and are used for immediate relief. LABAs are intended for maintenance therapy and are usually combined with inhaled corticosteroids, while SABAs serve as rescue medication.

Store the Neovent Cfc- Free Inhaler at temperatures below 25 °C, in its original packaging, protected from moisture and direct heat. Keep the device out of reach of children and avoid exposing it to freezing conditions, which could affect the propellant and dose consistency.

The inhaler is used by a patient after a full exhalation, placing the mouthpiece in the mouth, sealing lips around it, and inhaling slowly and deeply while actuating the device. The patient should hold their breath for about 10 seconds before exhaling, then repeat if a second puff is prescribed.

Serious adverse events include paradoxical bronchospasm (sudden worsening of breathing), cardiovascular effects such as palpitations, tachycardia, or arrhythmias, and hypersensitivity reactions like rash, angioedema, or anaphylaxis. Any of these symptoms require immediate medical attention.

Patients with a known hypersensitivity to salmeterol or any component of the inhaler should avoid its use. It is also contraindicated in individuals who experience severe paradoxical bronchospasm after inhalation. Caution is advised for patients with significant cardiovascular disease, uncontrolled hypertension, or those taking non‑selective β‑blockers.